Dmytruk Mark E.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Apr 4, 2024
- Accession no.
- 0001127602-24-012486
- Filed
- Apr 4, 2024
- Trade date
- Apr 1-2, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $53.7K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dmytruk Mark E.CIK 0001873507 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +65,448 | –F1 | – | 873,573 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +18,125 | –F1 | – | 891,698 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +22,916 | –F1 | – | 914,614 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,634 | –F3 | – | 916,248 | Direct | |
| Apr 2, 2024 | Class A Common Stock | SSaleDisposed | −51,169 | $1.05 | −$53,727.45 | 865,079 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −65,448 | –F1 | – | 712,436 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −18,125 | –F1 | – | 634,375 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −22,916 | –F1 | – | 1,077,084 | Direct | |
| Apr 1, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,634 | –F7 | – | 628,685 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Referenced by the price of 3 transactions in Table I and 3 transactions in Table II.
- F3
Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
Referenced by the price of 1 transaction in Table I.
- F7
Includes shares of Class B Common Stock that are subject to vesting conditions.
Referenced by the price of 1 transaction in Table II.
Remarks
Chief Financial Officer